Efficacy and safety of bevacizumab for the treatment of advanced hepatocellular carcinoma: a systematic review of phase II trials.

Efficacy and safety of bevacizumab for the treatment of advanced hepatocellular carcinoma: a systematic review of phase II trials.

<h4>Background</h4>Hepatocellular carcinoma (HCC) is a common cancer associated with a poor prognosis. Bevacizumab is a monoclonal antibody that binds vascular endothelial growth factor, a mediator of tumor angiogenesis. Bevacizumab is currently under investigation as treatment for HCC....

Full description

Saved in:
Bibliographic Details
Main Authors: Ping Fang, Jin-hua Hu, Zhi-gang Cheng, Zhe-feng Liu, Jin-liang Wang, Shun-chang Jiao
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2012-01-01
Series:PLoS ONE
Online Access:https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0049717&type=printable
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items